| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $134.8M | $125.9M | $143.6M |
| YoY Revenue Growth % | +7.1% | -12.3% | — |
| Gross Profit | $68.3M | $55.7M | — |
| Gross Margin % | 50.7% | 44.3% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $40.8M | $7.9M | -$17.5M |
| Operating Margin % | 30.3% | 6.2% | -12.2% |
| Net Income (GAAP) | $124.9M | -$100.7M | -$55.6M |
| EBITDA (Normalized) | $40.8M | $7.9M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $39.2M | -$16.1M | -$24.8M |
| Capital Expenditures (CapEx) | $0 | $54.0K | — |
| Free Cash Flow (FCF) | $39.2M | -$16.1M | -$24.8M |
| FCF Margin % | 29.1% | -12.8% | -17.2% |
| Return on Invested Capital (ROIC %) | 39.1% | 95.0% | — |
| Cash & Short-Term Equivalents | $10.3M | $4.4M | — |
| Total Debt (Short + Long Term) | $97.6M | $110.4M | — |
| Total Stockholders' Equity | -$4.8M | -$130.3M | — |